TY - JOUR T1 - Drugs for atopic dermatitis. PY - 2026/2/23/medline PY - 2026/2/23/pubmed PY - 2026/2/23/entrez KW - Adbry KW - Anzupgo KW - ApexiCon KW - Azasan KW - Cellcept KW - Cibinqo KW - Clobex KW - Desonide KW - Ebglyss KW - Eucrisa KW - Gengraf KW - Imuran KW - Nemluvio KW - Neoral KW - Olumiant KW - Opzelura KW - Otezla KW - Rasuvo KW - Rinvoq KW - Sernivo KW - Topicort KW - Ultravate KW - Vanos KW - Vtama KW - Zoryve KW - abrocitinib KW - adverse effects KW - alclometasone KW - amcinonide KW - antihistamines KW - apremilast KW - atopic dermatitis KW - azathioprine KW - baricitinib KW - betamethasone KW - clobetasol KW - clocortolone KW - corticosteroids KW - crisaborole KW - cyclosporine KW - delgocitinib KW - desoximetasone KW - diflorasone diacetate KW - dosage KW - efficacy KW - fluocinolone KW - fluocinonide KW - flurandrenolide KW - fluticasone propionate KW - halobetasol KW - hydrocortisone KW - immunotherapy KW - lactation KW - lebrikizumab KW - methotrexate KW - mometasone furoate KW - mycophenolate mofetil KW - nemolizumab KW - phototherapy KW - pimecrolimus KW - prednicarbate KW - pregnancy KW - probiotics KW - roflumilast KW - ruxolitinib KW - safety KW - tacrolimus KW - tapinarof KW - tralokinumab KW - triamcinolone acetonide KW - upadacitinib SP - 33 EP - 40 JF - The Medical letter on drugs and therapeutics JO - Med Lett Drugs Ther VL - 68 IS - 1749 SN - 1523-2859 UR - https://www.unboundmedicine.com/prime/citation/41730175/Drugs_for_atopic_dermatitis. DB - PRIME DP - Unbound Medicine ER -